Schonfeld Strategic Advisors’s Prelude Therapeutics PRLD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-18,000	Closed	-$94K	–	3015
2022 Q2	$94K	Buy	+18,000	New	+$94K	﹤0.01%	2079